Insights / Topic
Regulatory strategy
FDA, the EU, and the rules that shape how AI and software reach patients.
3
essays on this topic
- Life sciences strategy · Making Investment Decisions in China, EU and the United States as Drug Development Regulations Evolve: Technology isn’t just for Medtech, it’s about to Reshape Biotech as We Know it China has emerged as a strategic market, and a leader in some areas of biotech and medtech development, fundamentally altering development and investment landscapes.
- AI leadership · It’s an AI vs AI World in FDA Review FDA is now using even more sophisticated AI to review regulatory filings, and that impacts clinical trials and commercial strategy.
- Cybersecurity · What Developers and Hospital Administrators Need to Know about Cybersecurity in Today’s Medical Devices Cybersecurity just went prime time for medical devices. For hospital administrators that means new procurement and security challenges too.
Get in touch
Speaking, teaching, board work, or coaching
I am glad to hear from conference organizers, journalists, students, and leaders who want a thinking partner.